Landscapes / Companies
EyePoint Pharmaceuticals, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 4 in all
Trials
4 active
16 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 3 | Oct 2027Phase 3 trial completes | |||
| Next date | Oct 2027 · Phase 3 trial completes | ||||
| Also tested for | Wet Age Related Macular Degeneration, wAMD and 3 more | ||||
| Open drug page | |||||
About
- No active trial
- Dexycu, FAI insert, Razuprotafib
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021